Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Long-term outcomes after percutaneous patent foramen ovale closure.

Nagpal SV, Lerakis S, Flueckiger PB, Halista M, Willis P, Block PC, Douglas JS, Morris DC, Liff DA, Stewart J, Devireddy C, Veledar E, Nahab FB, Babaliaros VC.

Am J Med Sci. 2013 Sep;346(3):181-6. doi: 10.1097/MAJ.0b013e318276b071.

PMID:
23328836
2.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L; CLOSURE I Investigators..

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

3.

Long-term experience and outcomes with transcatheter closure of patent foramen ovale.

Inglessis I, Elmariah S, Rengifo-Moreno PA, Margey R, O'Callaghan C, Cruz-Gonzalez I, Baron S, Mehrotra P, Tan TC, Hung J, Demirjian ZN, Buonanno FS, Ning M, Silverman SB, Cubeddu RJ, Pomerantsev E, Schainfeld RM, Dec GW Jr, Palacios IF.

JACC Cardiovasc Interv. 2013 Nov;6(11):1176-83. doi: 10.1016/j.jcin.2013.06.013.

4.

Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.

Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A, Ageno W; FORI (Foramen Ovale Registro Italiano) Investigators..

Cerebrovasc Dis. 2011;31(2):109-16. doi: 10.1159/000321334.

PMID:
21088390
5.

Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.

Mirzaali M, Dooley M, Wynne D, Cooter N, Lee L, Haworth P, Saha R, Gainsborough N, Hildick-Smith D.

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):1078-84. doi: 10.1002/ccd.26080.

PMID:
26105198
6.

Ten years of experience with closure of persistent foramen ovale: patient characteristics and outcomes.

Lehmann R, Fichtlscherer S, Baldauf H, Schächinger V, Auch-Schwelck W, Zeiher AM, Teupe C.

J Cardiol. 2014 Aug;64(2):113-6. doi: 10.1016/j.jjcc.2013.11.020.

7.

Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.

Pickett CA, Villines TC, Ferguson MA, Hulten EA.

Tex Heart Inst J. 2014 Aug 1;41(4):357-67. doi: 10.14503/THIJ-13-3879. Review.

8.

Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.

Steinberg DH, Bertog SC, Momberger J, Franke J, Hofmann I, Renkhoff K, Joy S, Vaskelyte L, Sievert H.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1262-7. doi: 10.1002/ccd.25580.

PMID:
24948394
9.

Recurrent events after percutaneous closure of patent foramen ovale.

Wallenborn J, Bertog SC, Franke J, Steinberg DH, Majunke N, Wilson N, Wunderlich N, Sievert H.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):541-6. doi: 10.1002/ccd.24511.

PMID:
22707325
10.

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.

Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A.

Eur Heart J. 2013 Nov;34(43):3342-52. doi: 10.1093/eurheartj/eht285. Review.

PMID:
23847132
11.

Very long-term follow-up after percutaneous closure of patent foramen ovale.

Eeckhout E, Martin S, Delabays A, Michel P, Girod G.

EuroIntervention. 2015 Apr;10(12):1474-9. doi: 10.4244/EIJV10I12A257.

12.

Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.

Luermans JG, Post MC, Schräder R, Sluysmans T, Vydt T, Vermeersch P, Chessa M, Onorato E, Goy JJ, Budts WI.

Catheter Cardiovasc Interv. 2008 May 1;71(6):822-8. doi: 10.1002/ccd.21458.

PMID:
18324695
13.

Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.

Heinisch C, Bertog S, Wunderlich N, Majunke N, Baranowski A, Leetz M, Fischer E, Staubach S, Zimmermann W, Hofmann I, Sievert H.

EuroIntervention. 2012 Oct;8(6):717-23. doi: 10.4244/EIJV8I6A111.

14.

Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.

Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA.

JACC Cardiovasc Interv. 2013 Dec;6(12):1316-23. doi: 10.1016/j.jcin.2013.08.001. Review.

15.
16.

Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke.

Giardini A, Donti A, Formigari R, Salomone L, Palareti G, Guidetti D, Picchio FM.

Catheter Cardiovasc Interv. 2006 Apr;67(4):625-9.

PMID:
16548006
17.

Percutaneous closure of patent foramen ovale in cryptogenic embolism.

Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P; PC Trial Investigators..

N Engl J Med. 2013 Mar 21;368(12):1083-91. doi: 10.1056/NEJMoa1211716.

18.

Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.

Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, Räber L, Nedeltchev K, Mattle HP, Windecker S, Meier B.

Circulation. 2012 Feb 14;125(6):803-12. doi: 10.1161/CIRCULATIONAHA.111.030494.

19.

Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing?

Butera G, Biondi-Zoccai GG, Carminati M, Caputi L, Usai S, Bussone G, Meola G, Delogu AB, Sheiban I, Sangiorgi G.

Catheter Cardiovasc Interv. 2010 Mar 1;75(4):494-504. doi: 10.1002/ccd.22232. Review.

PMID:
20088014
20.

Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.

Diaz T, Cubeddu RJ, Rengifo-Moreno PA, Cruz-Gonzalez I, Solis-Martin J, Buonanno FS, Inglessis I, Palacios IF.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):145-50. doi: 10.1002/ccd.22475.

PMID:
20578100

Supplemental Content

Support Center